{
  "DOI": "10.1007/s12687-023-00655-x",
  "ISSN": [
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-023-00655-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003ePolygenic risk scores (PRS) have the potential to improve the accuracy of clinical risk assessments, yet questions about their clinical validity and readiness for clinical implementation persist. Understanding how individuals integrate and act on the information provided by PRS is critical for their effective integration into routine clinical care, yet few studies have examined how individuals respond to the receipt of polygenic risk information. We conducted an embedded Ethical, Legal, and Social Implications (ELSI) study to examine if and how unaffected participants in a US population breast cancer screening trial understood and utilized PRS, as part of a multifactorial risk score combining traditional risk factors with a genetic risk assessment, to make screening and risk-reduction decisions. Semi-structured qualitative interviews were conducted with 24 trial participants who were designated at elevated risk for breast cancer due to their combined risk score. Interviews were analyzed using a grounded theory approach. Participants understood PRS conceptually and accepted it as one of many risk factors to consider, yet the value and meaning they ascribed to this risk estimate varied. Most participants reported financial and insurance barriers to enhanced screening with MRI and were not interested in taking risk-reducing medications. These findings contribute to our understanding of how PRS may be best translated from research to clinical care. Furthermore, they illuminate ethical concerns about identifying risk and making recommendations based on polygenic risk in a population screening context where many may have trouble accessing appropriate care.\u003c/jats:p\u003e",
  "alternative-id": [
    "655"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "1 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "1 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "13 June 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethics approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the UCSF IRB (16–20352)."
    },
    {
      "group": {
        "label": "Consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Informed consent was obtained from all individual participants included in the study."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 5,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-1577-2762",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Riddle",
      "given": "Leslie",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-9179-7075",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Joseph",
      "given": "Galen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Caruncho",
      "given": "Mikaella",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3227-6768",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Koenig",
      "given": "Barbara Ann",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-6240-3487",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "James",
      "given": "Jennifer Elyse",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        6,
        13
      ]
    ],
    "date-time": "2023-06-13T16:02:06Z",
    "timestamp": 1686672126000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        10,
        14
      ]
    ],
    "date-time": "2023-10-14T04:18:50Z",
    "timestamp": 1697257130000
  },
  "funder": [
    {
      "DOI": "10.13039/100000002",
      "award": [
        "R01CA211999",
        "R01CA211999",
        "R01CA211999",
        "R01CA211999",
        "R01CA211999"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Institutes of Health"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        15
      ]
    ],
    "date-time": "2023-10-15T04:34:05Z",
    "timestamp": 1697344445994
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2023,
        6,
        13
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-online": {
      "date-parts": [
        [
          2023,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            13
          ]
        ],
        "date-time": "2023-06-13T00:00:00Z",
        "timestamp": 1686614400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            13
          ]
        ],
        "date-time": "2023-06-13T00:00:00Z",
        "timestamp": 1686614400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-023-00655-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-023-00655-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-023-00655-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "489-501",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        6,
        13
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        6,
        13
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/s41591-021-01549-6",
      "doi-asserted-by": "publisher",
      "key": "655_CR1",
      "unstructured": "Adeyemo A, Balaconis MK, Darnes DR, Fatumo S, Granados Moreno P, Hodonsky CJ, Inouye M, Kanai M, Kato K, Knoppers BM, Lewis ACF, Martin AR, McCarthy MI, Meyer MN, Okada Y, Richards JB, Richter L, Ripatti S, Rotimi CN, … Polygenic Risk Score Task Force of the International Common Disease Alliance (2021) Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat Med 27(11):1876–1884. https://doi.org/10.1038/s41591-021-01549-6"
    },
    {
      "key": "655_CR2",
      "unstructured": "Ambry Genetics (2020a) AmbryScore for Breast Cancer. https://www.ambrygen.com/clinician/ambryscore/breast. Accessed 21 Sept 2022"
    },
    {
      "DOI": "10.1016/j.jacadv.2022.100071",
      "author": "M Arvanitis",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "3",
      "journal-title": "JACC Adv",
      "key": "655_CR3",
      "unstructured": "Arvanitis M, Cainzos-Achirica M (2022) The road toward clinical implementation of polygenic risk scores for coronary artery disease∗. JACC Adv 1(3):1–3. https://doi.org/10.1016/j.jacadv.2022.100071",
      "volume": "1",
      "year": "2022"
    },
    {
      "key": "655_CR4",
      "unstructured": "ATLAS.ti (2022) https://atlasti.com/?x-clickref=1011lwneNxgx. Accessed 21 Sept 2022"
    },
    {
      "key": "655_CR5",
      "unstructured": "BCSC Breast Cancer Risk Calculator (n.d.) Retrieved October 3, 2020, from https://tools.bcsc-scc.org/BC5yearRisk/calculator.htm. Accessed 21 Sept 2022"
    },
    {
      "DOI": "10.3390/jpm11060511",
      "doi-asserted-by": "publisher",
      "key": "655_CR6",
      "unstructured": "Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Després P, Devilee P, Dorval M, Droit A, Easton DF, Eisen A, Eloy L, Fienberg S, Goldgar D, Hahnen E, Joly Y, Knoppers BM, Lofters A, Masson J-Y, … Simard J (2021) Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I\u0026I). J Personalized Med 11(6):511. https://doi.org/10.3390/jpm11060511"
    },
    {
      "DOI": "10.1007/s00439-022-02453-w",
      "author": "AJ Clarke",
      "doi-asserted-by": "publisher",
      "first-page": "1099",
      "issue": "5",
      "journal-title": "Hum Genet",
      "key": "655_CR7",
      "unstructured": "Clarke AJ, van El CG (2022) Genomics and justice: mitigating the potential harms and inequities that arise from the implementation of genomics in medicine. Hum Genet 141(5):1099–1107. https://doi.org/10.1007/s00439-022-02453-w",
      "volume": "141",
      "year": "2022"
    },
    {
      "DOI": "10.1186/s13073-018-0610-x",
      "doi-asserted-by": "publisher",
      "key": "655_CR8",
      "unstructured": "De La Vega FM, Bustamante CD (2018) Polygenic risk scores: a biased prediction? Genome Med 10:100. https://doi.org/10.1186/s13073-018-0610-x"
    },
    {
      "DOI": "10.1001/jama.2019.22241",
      "author": "J Elliott",
      "doi-asserted-by": "publisher",
      "first-page": "636",
      "issue": "7",
      "journal-title": "JAMA",
      "key": "655_CR9",
      "unstructured": "Elliott J, Bodinier B, Bond TA, Chadeau-Hyam M, Evangelou E, Moons KGM, Dehghan A, Muller DC, Elliott P, Tzoulaki I (2020) Predictive accuracy of a polygenic risk score–enhanced prediction model vs a clinical risk score for coronary artery disease. JAMA 323(7):636–645. https://doi.org/10.1001/jama.2019.22241",
      "volume": "323",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41523-017-0035-5",
      "author": "LJ Esserman",
      "doi-asserted-by": "publisher",
      "first-page": "34",
      "issue": "1",
      "journal-title": "Npj Breast Cancer",
      "key": "655_CR10",
      "unstructured": "Esserman LJ (2017) The WISDOM study: breaking the deadlock in the breast cancer screening debate. Npj Breast Cancer 3(1):34. https://doi.org/10.1038/s41523-017-0035-5",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-021-06346-w",
      "doi-asserted-by": "crossref",
      "key": "655_CR11",
      "unstructured": "Esserman L, Eklund M, Veer L van’t, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS (2021) The WISDOM study: a new approach to screening can and should be tested. In Breast Cancer Research and Treatment (vol 189, Issue 3, pp 593–598). Springer"
    },
    {
      "DOI": "10.1002/ijc.33782",
      "author": "DG Evans",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "655_CR12",
      "unstructured": "Evans DG, van Veen EM, Byers H, Roberts E, Howell A, Howell SJ, Harkness EF, Brentnall A, Cuzick J, Newman WG (2022) The importance of ethnicity: are breast cancer polygenic risk scores ready for women who are not of White European origin? Int J Cancer 150(1):73–79. https://doi.org/10.1002/ijc.33782",
      "volume": "150",
      "year": "2022"
    },
    {
      "DOI": "10.1245/s10434-019-07236-8",
      "author": "MR Flanagan",
      "doi-asserted-by": "publisher",
      "first-page": "2127",
      "issue": "7",
      "journal-title": "Ann Surg Oncol",
      "key": "655_CR13",
      "unstructured": "Flanagan MR, Zabor EC, Stempel M, Mangino DA, Morrow M, Pilewskie ML (2019) Chemoprevention uptake for breast cancer risk reduction varies by risk factor. Ann Surg Oncol 26(7):2127–2135. https://doi.org/10.1245/s10434-019-07236-8",
      "volume": "26",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s12687-018-0378-0",
      "author": "LE Forrest",
      "doi-asserted-by": "publisher",
      "first-page": "197",
      "issue": "2",
      "journal-title": "J Community Genet",
      "key": "655_CR14",
      "unstructured": "Forrest LE, Sawyer SD, Hallowell N, James PA, Young M-A (2019) High-risk women’s risk perception after receiving personalized polygenic breast cancer risk information. J Community Genet 10(2):197–206. https://doi.org/10.1007/s12687-018-0378-0",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.3390/jpm9020029",
      "author": "SB Haga",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "issue": "2",
      "journal-title": "J Personalized Med",
      "key": "655_CR15",
      "unstructured": "Haga SB, Kim E, Myers RA, Ginsburg GS (2019) Primary care physicians’ knowledge, attitudes, and experience with personal genetic testing. J Personalized Med 9(2):29. https://doi.org/10.3390/jpm9020029",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41591-022-01767-6",
      "doi-asserted-by": "publisher",
      "key": "655_CR16",
      "unstructured": "Hao L, Kraft P, Berriz GF, Hynes ED, Koch C, Korategere VKP, Parpattedar SS, Steeves M, Yu W, Antwi AA, Brunette CA, Danowski M, Gala MK, Green RC, Jones NE, Lewis ACF, Lubitz SA, Natarajan P, Vassy JL, Lebo MS (2022) Development of a clinical polygenic risk score assay and reporting workflow. Nat Med 28(5):Article 5. https://doi.org/10.1038/s41591-022-01767-6"
    },
    {
      "DOI": "10.1177/0272989X15594382",
      "author": "C Holmberg",
      "doi-asserted-by": "publisher",
      "first-page": "1010",
      "issue": "8",
      "journal-title": "Med Decis Making",
      "key": "655_CR17",
      "unstructured": "Holmberg C, Waters EA, Whitehouse K, Daly M, McCaskill-Stevens W (2015) My lived experiences are more important than your probabilities: the role of individualized risk estimates for decision making about participation in the Study of Tamoxifen and Raloxifene (STAR). Med Decis Making 35(8):1010–1022. https://doi.org/10.1177/0272989X15594382",
      "volume": "35",
      "year": "2015"
    },
    {
      "DOI": "10.1200/PO.20.00246",
      "author": "E Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "JCO Precis Oncol",
      "key": "655_CR18",
      "unstructured": "Hughes E, Tshiaba P, Wagner S, Judkins T, Rosenthal E, Roa B, Gallagher S, Meek S, Dalton K, Hedegard W, Adami CA, Grear DF, Domchek SM, Garber J, Lancaster JM, Weitzel JN, Kurian AW, Lanchbury JS, Gutin A, Robson ME (2021) Integrating clinical and polygenic factors to predict breast cancer risk in women undergoing genetic testing. JCO Precis Oncol 5:307–316. https://doi.org/10.1200/PO.20.00246",
      "volume": "5",
      "year": "2021"
    },
    {
      "DOI": "10.1002/jgc4.1617",
      "doi-asserted-by": "publisher",
      "key": "655_CR19",
      "unstructured": "James JE, Riddle L, Caruncho M, Koenig BA, Joseph G (2022) A qualitative study of unaffected ATM and CHEK2 carriers: how participants make meaning of ‘moderate risk’ genetic results in a population breast cancer screening trial. J Genet Couns n/a(n/a). https://doi.org/10.1002/jgc4.1617"
    },
    {
      "DOI": "10.1080/14636778.2022.2115348",
      "author": "JE James",
      "doi-asserted-by": "publisher",
      "first-page": "228",
      "issue": "3",
      "journal-title": "New Genet Soc",
      "key": "655_CR20",
      "unstructured": "James JE, Joseph G (2022) “It’s personalized, but it’s still bucket based”: the promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial. New Genet Soc 41(3):228–253. https://doi.org/10.1080/14636778.2022.2115348",
      "volume": "41",
      "year": "2022"
    },
    {
      "DOI": "10.1093/hmg/ddz205",
      "author": "ACJW Janssens",
      "doi-asserted-by": "publisher",
      "journal-title": "PubMed",
      "key": "655_CR21",
      "unstructured": "Janssens ACJW (2019) Validity of polygenic risk scores: are we measuring what we think we are? Human Molecular Genetics, 28(R2), R143–R150. PubMed. https://doi.org/10.1093/hmg/ddz205",
      "year": "2019"
    },
    {
      "DOI": "10.18865/ed.29.S1.173",
      "author": "S Jooma",
      "doi-asserted-by": "publisher",
      "first-page": "173",
      "issue": "Suppl 1",
      "journal-title": "Ethn Dis",
      "key": "655_CR22",
      "unstructured": "Jooma S, Hahn MJ, Hindorff LA, Bonham VL (2019) Defining and achieving health equity in genomic medicine. Ethn Dis 29(Suppl 1):173–178. https://doi.org/10.18865/ed.29.S1.173",
      "volume": "29",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41523-021-00288-8",
      "doi-asserted-by": "publisher",
      "key": "655_CR23",
      "unstructured": "Keane H, Huilgol YS, Shieh Y, Tice JA, Belkora J, Sepucha K, Shibley WP, Wang T, Che M, Goodman D, Ozanne E, Fiscalini AS, Esserman LJ (2021) Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial. Npj Breast Cancer 7(1):Article 1. https://doi.org/10.1038/s41523-021-00288-8"
    },
    {
      "DOI": "10.1038/s41588-018-0183-z",
      "author": "AV Khera",
      "doi-asserted-by": "publisher",
      "first-page": "1219",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "655_CR24",
      "unstructured": "Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, Natarajan P, Lander ES, Lubitz SA, Ellinor PT, Kathiresan S (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50(9):1219–1224. https://doi.org/10.1038/s41588-018-0183-z",
      "volume": "50",
      "year": "2018"
    },
    {
      "DOI": "10.1093/tbm/iby101",
      "author": "MK Ladd",
      "doi-asserted-by": "publisher",
      "first-page": "337",
      "issue": "2",
      "journal-title": "Trans Behav Med",
      "key": "655_CR25",
      "unstructured": "Ladd MK, Peshkin BN, Senter L, Baldinger S, Isaacs C, Segal H, Philip S, Phillips C, Shane K, Martin A, Weinstein V, Pilarski R, Jeter J, Sweet K, Hatten B, Wurtmann EJ, Phippen S, Bro D, Schwartz MD (2020) Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer. Trans Behav Med 10(2):337–346. https://doi.org/10.1093/tbm/iby101",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1093/hmg/ddz187",
      "author": "SA Lambert",
      "doi-asserted-by": "publisher",
      "first-page": "R133",
      "issue": "R2",
      "journal-title": "Hum Mol Genet",
      "key": "655_CR26",
      "unstructured": "Lambert SA, Abraham G, Inouye M (2019) Towards clinical utility of polygenic risk scores. Hum Mol Genet 28(R2):R133–R142. https://doi.org/10.1093/hmg/ddz187",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13073-021-00829-7",
      "author": "ACF Lewis",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "issue": "1",
      "journal-title": "Genome Medicine",
      "key": "655_CR27",
      "unstructured": "Lewis ACF, Green RC (2021) Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues. Genome Medicine 13(1):14. https://doi.org/10.1186/s13073-021-00829-7",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s13073-020-00742-5",
      "author": "CM Lewis",
      "doi-asserted-by": "publisher",
      "first-page": "44",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "655_CR28",
      "unstructured": "Lewis CM, Vassos E (2020) Polygenic risk scores: from research tools to clinical instruments. Genome Med 12(1):44. https://doi.org/10.1186/s13073-020-00742-5",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13073-022-01117-8",
      "author": "ACF Lewis",
      "doi-asserted-by": "publisher",
      "first-page": "114",
      "issue": "1",
      "journal-title": "Genome Medicine",
      "key": "655_CR29",
      "unstructured": "Lewis ACF, Perez EF, Prince AER, Flaxman HR, Gomez L, Brockman DG, Chandler PD, Kerman BJ, Lebo MS, Smoller JW, Weiss ST, Blout Zawatksy CL, Meigs JB, Green RC, Vassy JL, Karlson EW (2022) Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization. Genome Medicine 14(1):114. https://doi.org/10.1186/s13073-022-01117-8",
      "volume": "14",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41467-020-19966-5",
      "doi-asserted-by": "publisher",
      "key": "655_CR30",
      "unstructured": "Mars N, Widén E, Kerminen S, Meretoja T, Pirinen M, della Briotta Parolo P, Palta P, Havulinna A, Elliott A, Shcherban A, Ganna A, Jalanko A, Lehisto A, Kilpeläinen E, Brein G, Awaisa G, Laivuori H, Heyne H, Harju J, … FinnGen (2020) The role of polygenic risk and susceptibility genes in breast cancer over the course of life. Nat Commun 11(1):6383. https://doi.org/10.1038/s41467-020-19966-5"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.11.002",
      "doi-asserted-by": "publisher",
      "key": "655_CR31",
      "unstructured": "Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen T-H, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, … Easton DF (2019) Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet 104(1):21–34. https://doi.org/10.1016/j.ajhg.2018.11.002"
    },
    {
      "DOI": "10.1101/2021.04.26.21256141",
      "doi-asserted-by": "crossref",
      "key": "655_CR32",
      "unstructured": "Muse ED, Chen S-F, Liu S, Fernandez B, Schrader B, Molparia B, León AN, Lee R, Pubbi N, Mejia N (2021) Response to polygenic risk: results of the mygenerank mobile application-based coronary artery disease study. MedRxiv"
    },
    {
      "key": "655_CR33",
      "unstructured": "Myriad Genetics (2020b) Introducing riskScoreTM: a groundbreaking breast cancer risk-prediction tool. ambry"
    },
    {
      "key": "655_CR34",
      "unstructured": "National Human Genome Research Institute (2021) Polygenic RIsk MEthods in Diverse populations (PRIMED) consortium. https://www.genome.gov/Funded-Programs-Projects/PRIMED-Consortium. Accessed 21 Sept 2022"
    },
    {
      "DOI": "10.1200/JCO.2009.27.8077",
      "author": "ME Ropka",
      "doi-asserted-by": "publisher",
      "first-page": "3090",
      "issue": "18",
      "journal-title": "J Clin Oncol",
      "key": "655_CR35",
      "unstructured": "Ropka ME, Keim J, Philbrick JT (2010) Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol 28(18):3090–3095. https://doi.org/10.1200/JCO.2009.27.8077",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s12885-022-09484-6",
      "author": "A Roux",
      "doi-asserted-by": "publisher",
      "first-page": "507",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "655_CR36",
      "unstructured": "Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, Balleyguier C, Guindy M, Gilbert FJ, Burrion J-B, Castells X, Ritchie D, Keatley D, Baron C, Delaloge S, de Montgolfier S (2022) Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial. BMC Cancer 22(1):507. https://doi.org/10.1186/s12885-022-09484-6",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1002/jgc4.1386",
      "author": "MLB Schwartz",
      "doi-asserted-by": "publisher",
      "first-page": "634",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "655_CR37",
      "unstructured": "Schwartz MLB, Buchanan AH, Hallquist MLG, Haggerty CM, Sturm AC (2021) Genetic counseling for patients with positive genomic screening results: considerations for when the genetic test comes first. J Genet Couns 30(3):634–644. https://doi.org/10.1002/jgc4.1386",
      "volume": "30",
      "year": "2021"
    },
    {
      "DOI": "10.1159/000518415",
      "doi-asserted-by": "publisher",
      "key": "655_CR38",
      "unstructured": "Sharma Y, Cox L, Kruger L, Channamsetty V, Haga SB (2021) Evaluating primary care providers’ readiness for delivering genetic and genomic services to underserved populations. Public Health Genomics 1–10. https://doi.org/10.1159/000518415"
    },
    {
      "DOI": "10.1093/jnci/djw290",
      "doi-asserted-by": "publisher",
      "key": "655_CR39",
      "unstructured": "Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Veer VJL, Esserman LJ, Tice JA (2017) Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. JNCI: J Natl Cancer Inst 109(5). https://doi.org/10.1093/jnci/djw290"
    },
    {
      "DOI": "10.1093/annonc/mdv590",
      "doi-asserted-by": "publisher",
      "key": "655_CR40",
      "unstructured": "Smith SG, Sestak I, Forster A, Partridge A, Side L, Wolf MS, Horne R, Wardle J, Cuzick J (2016) Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol 27(4):575–590. PubMed. https://doi.org/10.1093/annonc/mdv590"
    },
    {
      "DOI": "10.1186/s13053-016-0061-6",
      "author": "E Steel",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Hereditary Cancer Clin Pract",
      "key": "655_CR41",
      "unstructured": "Steel E, Robbins A, Jenkins M, Flander L, Gaff C, Keogh L (2017) How does genetic risk information for Lynch syndrome translate to risk management behaviours? Hereditary Cancer Clin Pract 15(1):1. https://doi.org/10.1186/s13053-016-0061-6",
      "volume": "15",
      "year": "2017"
    },
    {
      "DOI": "10.1111/bjd.20956",
      "author": "J Steinberg",
      "doi-asserted-by": "publisher",
      "first-page": "823",
      "issue": "5",
      "journal-title": "Br J Dermatol",
      "key": "655_CR42",
      "unstructured": "Steinberg J, Iles MM, Lee JY, Wang X, Law MH, Smit AK, Nguyen-Dumont T, Giles GG, Southey MC, Milne RL, Mann GJ, Bishop DT, MacInnis RJ, Cust AE (2022) Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts*. Br J Dermatol 186(5):823–834. https://doi.org/10.1111/bjd.20956",
      "volume": "186",
      "year": "2022"
    },
    {
      "author": "A Strauss",
      "key": "655_CR43",
      "unstructured": "Strauss A, Corbin J (1997) Grounded theory in practice. Sage Publications Inc",
      "volume-title": "Grounded theory in practice",
      "year": "1997"
    },
    {
      "DOI": "10.1016/j.gim.2022.03.006",
      "author": "SA Suckiel",
      "doi-asserted-by": "publisher",
      "journal-title": "Genet Med",
      "key": "655_CR44",
      "unstructured": "Suckiel SA, Braganza GT, Aguiñiga KL, Odgis JA, Bonini KE, Kenny EE, Hamilton JG, Abul-Husn NS (2022) Perspectives of diverse Spanish- and English-speaking patients on the clinical use of polygenic risk scores. Genet Med. https://doi.org/10.1016/j.gim.2022.03.006",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41576-018-0018-x",
      "author": "A Torkamani",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "issue": "9",
      "journal-title": "Nat Rev Genet",
      "key": "655_CR45",
      "unstructured": "Torkamani A, Wineinger NE, Topol EJ (2018) The personal and clinical utility of polygenic risk scores. Nat Rev Genet 19(9):581–590. https://doi.org/10.1038/s41576-018-0018-x",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.gim.2022.09.008",
      "author": "CK Wallingford",
      "doi-asserted-by": "publisher",
      "journal-title": "Genet Med",
      "key": "655_CR46",
      "unstructured": "Wallingford CK, Kovilpillai H, Jacobs C, Turbitt E, Primiero CA, Young M-A, Brockman DG, Soyer HP, McInerney-Leo AM, Yanes T (2022) Models of communication for polygenic scores and associated psychosocial and behavioral effects on recipients: a systematic review. Genet Med. https://doi.org/10.1016/j.gim.2022.09.008",
      "year": "2022"
    },
    {
      "DOI": "10.1161/CIRCGEN.121.003459",
      "doi-asserted-by": "crossref",
      "key": "655_CR47",
      "unstructured": "Widén E, Junna N, Ruotsalainen S, Surakka I, Mars N, Ripatti P, Partanen JJ, Aro J, Mustonen P, Tuomi T (2022) How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study. Circ: Genomic Precis Med 15(2):e003459"
    },
    {
      "DOI": "10.1002/jgc4.1384",
      "author": "AM Willis",
      "doi-asserted-by": "publisher",
      "first-page": "849",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "655_CR48",
      "unstructured": "Willis AM, Smith SK, Meiser B, James PA, Ballinger ML, Thomas DM, Yanes T, Young M-A (2021) Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: ‘Another piece of the pie.’ J Genet Couns 30(3):849–860. https://doi.org/10.1002/jgc4.1384",
      "volume": "30",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10689-020-00185-2",
      "author": "T Yanes",
      "doi-asserted-by": "publisher",
      "first-page": "297",
      "issue": "4",
      "journal-title": "Fam Cancer",
      "key": "655_CR49",
      "unstructured": "Yanes T, Kaur R, Meiser B, Scheepers-Joynt M, McInerny S, Barlow-Stewart K, Antill Y, Salmon L, Smyth C, James PA, Young MA (2020) Women’s responses and understanding of polygenic breast cancer risk information. Fam Cancer 19(4):297–306. https://doi.org/10.1007/s10689-020-00185-2",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41436-021-01288-6",
      "author": "T Yanes",
      "doi-asserted-by": "publisher",
      "first-page": "2316",
      "issue": "12",
      "journal-title": "Genet Med",
      "key": "655_CR50",
      "unstructured": "Yanes T, Meiser B, Kaur R, Young M-A, Mitchell PB, Scheepers-Joynt M, McInerny S, Taylor S, Barlow-Stewart K, Antill Y, Salmon L, Smyth C, Betz-Stablein B, James PA (2021) Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior. Genet Med 23(12):2316–2323. https://doi.org/10.1038/s41436-021-01288-6",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s10897-017-0162-z",
      "author": "M-A Young",
      "doi-asserted-by": "publisher",
      "first-page": "702",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "655_CR51",
      "unstructured": "Young M-A, Forrest LE, Rasmussen V-M, James P, Mitchell G, Sawyer SD, Reeve K, Hallowell N (2018) Making sense of SNPs: women’s understanding and experiences of receiving a personalized profile of their breast cancer risks. J Genet Couns 27(3):702–708. https://doi.org/10.1007/s10897-017-0162-z",
      "volume": "27",
      "year": "2018"
    }
  ],
  "reference-count": 51,
  "references-count": 51,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-023-00655-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "The role of polygenic risk scores in breast cancer risk perception and decision-making"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}